191 related articles for article (PubMed ID: 12150695)
1. Treatment of polycystic ovary syndrome with insulin-lowering agents.
Glueck CJ; Streicher P; Wang P
Expert Opin Pharmacother; 2002 Aug; 3(8):1177-89. PubMed ID: 12150695
[TBL] [Abstract][Full Text] [Related]
2. Insulin resistance, polycystic ovary syndrome and metformin.
Pugeat M; Ducluzeau PH
Drugs; 1999; 58 Suppl 1():41-6; discussion 75-82. PubMed ID: 10576524
[TBL] [Abstract][Full Text] [Related]
3. Insulin and the polycystic ovary syndrome.
Macut D; Bjekić-Macut J; Rahelić D; Doknić M
Diabetes Res Clin Pract; 2017 Aug; 130():163-170. PubMed ID: 28646699
[TBL] [Abstract][Full Text] [Related]
4. Should patients with polycystic ovary syndrome be treated with metformin? Benefits of insulin sensitizing drugs in polycystic ovary syndrome--beyond ovulation induction.
Stadtmauer LA; Wong BC; Oehninger S
Hum Reprod; 2002 Dec; 17(12):3016-26. PubMed ID: 12456596
[TBL] [Abstract][Full Text] [Related]
5. Should insulin-sensitizing drugs be used in the treatment of polycystic ovary syndrome?
Cheang KI; Nestler JE
Reprod Biomed Online; 2004 Apr; 8(4):440-7. PubMed ID: 15149568
[TBL] [Abstract][Full Text] [Related]
6. Insulin-sensitisers in the treatment of polycystic ovary syndrome.
Teede HJ; Meyer C; Norman RJ
Expert Opin Pharmacother; 2005 Nov; 6(14):2419-27. PubMed ID: 16259573
[TBL] [Abstract][Full Text] [Related]
7. Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis.
Naderpoor N; Shorakae S; de Courten B; Misso ML; Moran LJ; Teede HJ
Hum Reprod Update; 2015; 21(5):560-74. PubMed ID: 26060208
[TBL] [Abstract][Full Text] [Related]
8. Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome.
Lord JM; Flight IH; Norman RJ
Cochrane Database Syst Rev; 2003; (3):CD003053. PubMed ID: 12917943
[TBL] [Abstract][Full Text] [Related]
9. Should patients with polycystic ovarian syndrome be treated with metformin?
Seli E; Duleba AJ
Hum Reprod; 2002 Sep; 17(9):2230-6. PubMed ID: 12202407
[TBL] [Abstract][Full Text] [Related]
10. Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome.
Tso LO; Costello MF; Albuquerque LE; Andriolo RB; Freitas V
Cochrane Database Syst Rev; 2009 Apr; (2):CD006105. PubMed ID: 19370625
[TBL] [Abstract][Full Text] [Related]
11. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.
Tang T; Lord JM; Norman RJ; Yasmin E; Balen AH
Cochrane Database Syst Rev; 2009 Oct; (4):CD003053. PubMed ID: 19821299
[TBL] [Abstract][Full Text] [Related]
12. Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy.
Teede HJ; Meyer C; Hutchison SK; Zoungas S; McGrath BP; Moran LJ
Fertil Steril; 2010 Jan; 93(1):184-91. PubMed ID: 19019358
[TBL] [Abstract][Full Text] [Related]
13. The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome.
Unlühizarci K; Keleştimur F; Bayram F; Sahin Y; Tutuş A
Clin Endocrinol (Oxf); 1999 Aug; 51(2):231-6. PubMed ID: 10468995
[TBL] [Abstract][Full Text] [Related]
14. Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance.
Arslanian SA; Lewy V; Danadian K; Saad R
J Clin Endocrinol Metab; 2002 Apr; 87(4):1555-9. PubMed ID: 11932281
[TBL] [Abstract][Full Text] [Related]
15. Insulin resistance and metformin in polycystic ovary syndrome.
Ben-Haroush A; Yogev Y; Fisch B
Eur J Obstet Gynecol Reprod Biol; 2004 Aug; 115(2):125-33. PubMed ID: 15262344
[TBL] [Abstract][Full Text] [Related]
16. Use of metformin in polycystic ovary syndrome.
Mathur R; Alexander CJ; Yano J; Trivax B; Azziz R
Am J Obstet Gynecol; 2008 Dec; 199(6):596-609. PubMed ID: 19084097
[TBL] [Abstract][Full Text] [Related]
17. Polycystic ovary syndrome and metabolic comorbidities: therapeutic options.
De Leo V; Musacchio MC; Palermo V; Di Sabatino A; Morgante G; Petraglia F
Drugs Today (Barc); 2009 Oct; 45(10):763-75. PubMed ID: 20069140
[TBL] [Abstract][Full Text] [Related]
18. Medical therapy in women with polycystic ovarian syndrome before and during pregnancy and lactation.
Goldenberg N; Glueck C
Minerva Ginecol; 2008 Feb; 60(1):63-75. PubMed ID: 18277353
[TBL] [Abstract][Full Text] [Related]
19. Insulin-sensitizing agents in the treatment of polycystic ovary syndrome: an update.
Katsiki N; Hatzitolios AI
Curr Opin Obstet Gynecol; 2010 Dec; 22(6):466-76. PubMed ID: 20724929
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance, insulin sensitization and inflammation in polycystic ovarian syndrome.
Dhindsa G; Bhatia R; Dhindsa M; Bhatia V
J Postgrad Med; 2004; 50(2):140-4. PubMed ID: 15235215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]